PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy.\', \'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano MI, Italy.\', \'DiaSorin S.p.A., Saluggia VC, Italy.\', \'William Harvey Research Institute, Queen Mary University of London, London, UK.\', \'Department of Biomedical Sciences, Humanitas University, Pieve Emanuele MI, Italy maria.rescigno@hunimed.eu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e20220138110.26508/lsa.202201381
?:hasPublicationType
?:journal
  • Life science alliance
is ?:pmid of
?:pmid
?:pmid
  • 35169017
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35169017>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35169017>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all